Document Detail

Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action.
MedLine Citation:
PMID:  20963488     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Bufalin, a naturally occurring small-molecule compound from Traditional Chinese Medicine (TCM) Chansu showed inhibitory effects against human prostate, hepatocellular, endometrial and ovarian cancer cells, and leukemia cells. However, whether or not bufalin has inhibitory activity against the proliferation of human non-small cell lung cancer (NSCLC) cells is unclear. The aim of this study is to study the effects of bufalin on the proliferation of NSCLC and its molecular mechanisms of action. The cancer cell proliferation was measured by MTT assay. The apoptosis and cell cycle distribution were analyzed by flow cytometry. The protein expressions and phosphorylation in the cancer cells were detected by Western blot analysis. In the present study, we have demonstrated that bufalin suppressed the proliferation of human NSCLC A549 cell line in time- and dose-dependent manners. Bufalin induced the apoptosis and cell cycle arrest by affecting the protein expressions of Bcl-2/Bax, cytochrome c, caspase-3, PARP, p53, p21WAF1, cyclinD1, and COX-2 in A549 cells. In addition, bufalin reduced the protein levels of receptor expressions and/or phosphorylation of VEGFR1, VEGFR2, EGFR and/or c-Met in A549 cells. Furthermore, bufalin inhibited the protein expressions and phosphorylation of Akt, NF-κB, p44/42 MAPK (ERK1/2) and p38 MAPK in A549 cells. Our results suggest that bufalin inhibits the human lung cancer cell proliferation via VEGFR1/VEGFR2/EGFR/c-Met-Akt/p44/42/p38-NF-κB signaling pathways; bufalin may have a wide therapeutic and/or adjuvant therapeutic application in the treatment of human NSCLC.
Yongtao Jiang; Ying Zhang; Jinling Luan; Huiying Duan; Feng Zhang; Kazumi Yagasaki; Guoying Zhang
Related Documents :
10408308 - Adenosquamous carcinoma of the prostate.
17867958 - Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro.
11418018 - Peroxisome proliferator-activated receptor- gamma expression in human malignant and nor...
7690358 - Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer ce...
18405668 - Enhanced ubiquitin-proteasome activity in calreticulin deficient cells: a compensatory ...
24891448 - Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant gl...
Publication Detail:
Type:  Journal Article     Date:  2010-10-21
Journal Detail:
Title:  Cytotechnology     Volume:  62     ISSN:  0920-9069     ISO Abbreviation:  Cytotechnology     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-01     Completed Date:  2011-11-10     Revised Date:  2011-12-21    
Medline Journal Info:
Nlm Unique ID:  8807027     Medline TA:  Cytotechnology     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  573-83     Citation Subset:  -    
Laboratory of Molecular Pharmacology, School of Pharmacy, Yantai University, No. 30, Qing Quan Lu, Lai Shan Qu, 264005, Yantai, Shandong Province, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neurochemicals for the Investigation of GABA(C) receptors.
Next Document:  Simple assessment of patient's stage of chronic kidney disease using eGFR-MDRD nomograms.